Squarepoint’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Sell
55,000
-89,900
-62% -$2.41M ﹤0.01% 2378
2026
Q1
$3.01M Sell
144,900
-1,744,100
-92% -$41.2M ﹤0.01% 1892
2025
Q4
$61.3M Buy
1,889,000
+1,518,500
+410% +$65M 0.07% 338
2025
Q3
$21M Buy
370,500
+221,600
+149% +$11.4M 0.02% 719
2025
Q2
$7.42M Sell
148,900
-78,900
-35% -$3.57M 0.01% 1234
2025
Q1
$6.73M Buy
227,800
+75,100
+49% +$2.79M 0.01% 1250
2024
Q4
$3.69M Buy
152,700
+108,000
+242% +$2.68M ﹤0.01% 1886
2024
Q3
$823K Sell
44,700
-33,000
-42% -$591K ﹤0.01% 2757
2024
Q2
$1.57M Buy
+77,700
New +$1.29M ﹤0.01% 2226

Other funds holding HIMS

Squarepoint's HIMS Position: Q2 2026 in Review

Squarepoint increased its Hims & Hers Health (HIMS) stake by 2,191% in Q2 2026, buying an estimated $15.8M and bringing the position to 617,308 shares worth $21.4M. The position accounts for 0.02% of the portfolio, ranked #670.

Squarepoint first reported a position in HIMS in Q1 2021 and has held it in 18 quarters since. The position peaked at $57.9M in Q2 2025. 507 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Squarepoint held 617,308 shares of Hims & Hers Health worth $21.4M as of Q2 2026.
  • Squarepoint bought 590,360 Hims & Hers Health shares in Q2 2026, an estimated $15.8M.
  • Hims & Hers Health made up 0.02% of Squarepoint's portfolio in Q2 2026, its #670 holding.
  • Squarepoint first reported a position in Hims & Hers Health in Q1 2021 and has held it in 18 quarters since.
  • Squarepoint's Hims & Hers Health position peaked at $57.9M in Q2 2025.
  • 507 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.